|
MANEA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.162000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.943600E-01 |
| Normal-vs-Stage2 |
4.600400E-01 |
| Normal-vs-Stage3 |
7.042400E-02 |
| Normal-vs-Stage4 |
1.177500E-03 |
| Stage1-vs-Stage2 |
4.034800E-01 |
| Stage1-vs-Stage3 |
1.325160E-01 |
| Stage1-vs-Stage4 |
4.160700E-03 |
| Stage2-vs-Stage3 |
1.243780E-01 |
| Stage2-vs-Stage4 |
3.120300E-02 |
| Stage3-vs-Stage4 |
2.350000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.206000E-01 |
| Normal-vs-AfricanAmerican |
1.29509999946542E-07 |
| Normal-vs-Asian |
3.012200E-02 |
| Caucasian-vs-AfricanAmerican |
6.7371000000982E-07 |
| Caucasian-vs-Asian |
3.509200E-01 |
| AfricanAmerican-vs-Asian |
6.429800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.291700E-02 |
| Normal-vs-Female |
9.508000E-01 |
| Male-vs-Female |
1.465020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.840000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.551800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.963440E-01 |
| Normal-vs-Age(81-100Yrs) |
7.272800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.728180E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.540100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.211230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.675200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.297600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.613400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.310400E-01 |
| Normal-vs-Grade 2 |
4.111000E-01 |
| Normal-vs-Grade 3 |
1.702150E-02 |
| Normal-vs-Grade 4 |
6.73269999973414E-07 |
| Grade 1-vs-Grade 2 |
5.630200E-01 |
| Grade 1-vs-Grade 3 |
4.787600E-02 |
| Grade 1-vs-Grade 4 |
6.772000E-04 |
| Grade 2-vs-Grade 3 |
8.635000E-03 |
| Grade 2-vs-Grade 4 |
1.08399999998454E-06 |
| Grade 3-vs-Grade 4 |
2.382600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.660200E-03 |
| Normal-vs-ccB subtype |
2.570300E-04 |
| ccA subtype-vs-ccB subtype |
1.28299999513359E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.119600E-01 |
| Normal-vs-N1 |
5.504100E-02 |
| N0-vs-N1 |
1.323560E-01 |
|
|
